Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (websockets) API Google Sheets add-on Excel add-on
Community
Academy 134 articles Forum Github 13 repos
Marketplace
Spreadsheets
Google Sheets add-on Excel add-on Wordpress plugin
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. NASDAQ /
  3. INM.NASDAQ

InMed Pharmaceuticals Inc (INM NASDAQ) stock market data APIs

$0.2882 -0(-0%) as of July 26, 2024
Price chart is built with Anychart

InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, develops a pipeline of prescription-based products. The company operates through two segments, the InMed and the BayMedica. The InMed segment researches and develops cannabinoid-based pharmaceuticals products. The BayMedica segment develops proprietary manufacturing technologies to produce and sell rare cannabinoids for the health and wellness industry. Its prescription-based products include rare cannabinoids and novel cannabinoid analogs for the treatment of diseases with high unmet medical needs. The company's lead product is INM-755, a cannabinol topical skin cream, completed Phase 2 clinical trial for the treatment of epidermolysis bullosa. It also develops INM-088, which is in preclinical studies for the treatment of glaucoma; and INM-900 for neurodegenerative diseases. In addition, the company offers IntegraSyn, an integrated biosynthesis-based manufacturing approach, for pharmaceutical-grade cannabinoids; and cannabichromene, cannabicitran, cannabidivarin, and tetrahydrocannabivarin. The company was formerly known as Cannabis Technologies Inc. and changed its name to InMed Pharmaceuticals Inc. in October 2014. InMed Pharmaceuticals Inc. was incorporated in 1981 and is headquartered in Vancouver, Canada.

InMed Pharmaceuticals Inc Financial Data Overview

0.2885
0.2882
-
0.2949
0.267
0.2122-1.17
2 506 K
8 919 K
5 626 K
-0.1792
0.597
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'INM',
Type: 'Common Stock',
Name: 'InMed Pharmaceuticals Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG000BT4589',
ISIN: 'CA4576375022',
CUSIP: NULL,
CIK: '1728328',
EmployerIdNumber: NULL,
FiscalYearEnd: 'June',
IPODate: '2020-11-12',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,
}

InMed Pharmaceuticals Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 5 626 K
  • EBITDA -6 423 389
  • Earnings Per Share -0.54
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get InMed Pharmaceuticals Inc Earnings via APIs

  • Latest Release 2024-05-14
  • EPS/Forecast NaN

Get InMed Pharmaceuticals Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get InMed Pharmaceuticals Inc latest news via APIs

Life Sciences Virtual Investor Forum: Presentations Now Available for Online Viewing

Virtual Investor Conferences Company Executives Share Vision and Answer Questions at VirtualInvestorConferences.com NEW YORK, March 10, 2023 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the lea...
  • COMPANY PRESENTATIONS
  • INVESTOR CONFERENCE
  • INVESTOR CONFERENCES
  • THE LIFE SCIENCES VIRTUAL INVESTOR FORUM
  • VIRTUAL INVESTOR CONFERENCES

Life Sciences Virtual Investor Forum Agenda Announced for March 9th

Virtual Investor Conferences Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com NEW YORK, March 07, 2023 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, th...
  • INDIVIDUAL INVESTORS
  • INSTITUTIONAL INVESTORS
  • INVESTOR CONFERENCE
  • VIRTUAL INVESTOR CONFERENCES
Do you have any questions?
support@eodhistoricaldata.com